Latest Articles
![We strive to revolutionize mental health research We strive to revolutionize mental health research](/sites/default/files/2023-09/brain.jpg)
Science Stories
Striving to revolutionize mental health research
Through a precision psychiatry approach and rich pipeline, we are committed to transforming the mental health landscape
Read more
![Scientists from the Chemical Development department at Boehringer Ingelheim Group of scientists from the Chemical Development department at Boehringer Ingelheim gathering in the kilolab facilities, where the first kilogram quantities of the drug substance is manufactured](/sites/default/files/2023-07/Picture_AnnikaGille_Development.jpg)
Science Stories
Targeting MDM2-p53 in cancer: The story of brigimadlin
Our perseverance and passion for science led to the discovery of brigimadlin, our MDM2-p53 antagonist. It is being clinically investigated as a potential treatment for dedifferentiated liposarcoma, a rare cancer with significant unmet needs.
Read more
![Biological Development Center in Biberach, Germany Exterior view of the Biologicals Development Center](/sites/default/files/2023-07/BDC%20Au%C3%9Fenansicht_1_small.jpg)
Science Stories
The Biologicals Development Center
Europe’s largest biotechnology center in Biberach, Germany is the home to three development units.
Read more